The detection of autoantibodies in the lung cancer patients and the study of clinical significance

The detection of autoantibodies in the lung cancer patients and the study of clinical significance - The detection of autoantibodies in the lung cancer patients and the study of clinical significance

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025154

Enrollment

200

Registered

2016-12-07

Start date

2016-12-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Pathologically-confirmed lung cancer 2.Written voluntary informed consent 3.Patients aged>=20 years 4.Male or female 5.Hospitalized patients or outpatients

Exclusion criteria

Exclusion criteria: 1.Cases determined by the investigator or the attending physician to be unsuitable as a subject in this study

Design outcomes

Primary

Measure	Time frame
The association between the serum antibodities levels and diagnosis	—

Countries

Japan

Contacts

Public ContactTakanobu Jotatsu

University of Occupational and Environmental Health, Japan Dept. of Respiratory Medicine

jotatsu-t@med.uoeh-u.ac.jp093-691-7453

Outcome results